UT MD ANDERSON CANCER CENTER — History
CCN 450076 | 3-year financial timeline | COVID resilience: 65/100
🛡️ Public data only — no PHI permitted on this instance.
$4.9B
Latest Revenue (FY2022)
+10.9%
Revenue CAGR (3yr)
-0.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $4.0B | $4.4B | $4.9B | +11.3% | +10.9% |
| Operating Expenses | $4.1B | $4.5B | $4.9B | +9.7% | +10.3% |
| Operating Margin | -2.0% | -2.3% | -0.8% | +65.3% | +0.0% |
| Net Income | $-81M | $-101M | $-39M | +61.3% | +0.0% |
| Licensed Beds | 739 | 698 | 721 | +3.3% | -1.2% |
| Total Patient Days | 203,443 | 209,271 | 229,331 | +9.6% | +6.2% |
| Medicare Day % | 33% | 35% | 32% | -7.5% | -0.7% |
| Medicaid Day % | 1% | 1% | 0% | -28.0% | -27.9% |
COVID Impact & Recovery
Resilience Score: 65/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +23.0% ($4.0B → $4.9B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+10.9%
This Hospital
+7.6%
State Avg
Latest Margin
-0.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $5.4B | -0.2% |
| FY2024 (proj) | $5.8B | 0.4% |
| FY2025 (proj) | $6.3B | 1.0% |